1. Home
  2. MYND vs LEXX Comparison

MYND vs LEXX Comparison

Compare MYND & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYND
  • LEXX
  • Stock Information
  • Founded
  • MYND 1998
  • LEXX 2004
  • Country
  • MYND Cayman Islands
  • LEXX Canada
  • Employees
  • MYND N/A
  • LEXX N/A
  • Industry
  • MYND Other Consumer Services
  • LEXX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MYND Real Estate
  • LEXX Health Care
  • Exchange
  • MYND Nasdaq
  • LEXX Nasdaq
  • Market Cap
  • MYND 31.7M
  • LEXX 49.3M
  • IPO Year
  • MYND 2017
  • LEXX N/A
  • Fundamental
  • Price
  • MYND $1.38
  • LEXX $2.98
  • Analyst Decision
  • MYND
  • LEXX Strong Buy
  • Analyst Count
  • MYND 0
  • LEXX 2
  • Target Price
  • MYND N/A
  • LEXX $11.00
  • AVG Volume (30 Days)
  • MYND 115.2K
  • LEXX 96.0K
  • Earning Date
  • MYND 11-03-2024
  • LEXX 11-18-2024
  • Dividend Yield
  • MYND N/A
  • LEXX N/A
  • EPS Growth
  • MYND N/A
  • LEXX N/A
  • EPS
  • MYND N/A
  • LEXX N/A
  • Revenue
  • MYND $357,050,000.00
  • LEXX $411,019.00
  • Revenue This Year
  • MYND N/A
  • LEXX $82.02
  • Revenue Next Year
  • MYND N/A
  • LEXX $95.09
  • P/E Ratio
  • MYND N/A
  • LEXX N/A
  • Revenue Growth
  • MYND N/A
  • LEXX 34.05
  • 52 Week Low
  • MYND $0.61
  • LEXX $0.90
  • 52 Week High
  • MYND $14.20
  • LEXX $6.85
  • Technical
  • Relative Strength Index (RSI)
  • MYND 60.52
  • LEXX 41.43
  • Support Level
  • MYND $0.61
  • LEXX $2.91
  • Resistance Level
  • MYND $1.38
  • LEXX $3.39
  • Average True Range (ATR)
  • MYND 0.17
  • LEXX 0.20
  • MACD
  • MYND 0.08
  • LEXX -0.02
  • Stochastic Oscillator
  • MYND 64.68
  • LEXX 13.49

About MYND Mynd.ai Inc.

Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. The Company has four reportable segments: Intellectual Property Licensing, B2B Production, Research and Development and Corporate. It earns maximum revenue from Intellectual Property Licensing.

Share on Social Networks: